chr1-40310265-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001852.4(COL9A2):​c.737C>T​(p.Thr246Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.032 in 1,614,028 control chromosomes in the GnomAD database, including 1,056 homozygotes. In-silico tool predicts a benign outcome for this variant. 18/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T246T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.021 ( 61 hom., cov: 32)
Exomes 𝑓: 0.033 ( 995 hom. )

Consequence

COL9A2
NM_001852.4 missense, splice_region

Scores

18
Splicing: ADA: 0.0001059
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.167

Publications

13 publications found
Variant links:
Genes affected
COL9A2 (HGNC:2218): (collagen type IX alpha 2 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
COL9A2 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Stickler syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0078905225).
BP6
Variant 1-40310265-G-A is Benign according to our data. Variant chr1-40310265-G-A is described in CliVar as Benign. Clinvar id is 258393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40310265-G-A is described in CliVar as Benign. Clinvar id is 258393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40310265-G-A is described in CliVar as Benign. Clinvar id is 258393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40310265-G-A is described in CliVar as Benign. Clinvar id is 258393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40310265-G-A is described in CliVar as Benign. Clinvar id is 258393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40310265-G-A is described in CliVar as Benign. Clinvar id is 258393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40310265-G-A is described in CliVar as Benign. Clinvar id is 258393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0214 (3261/152252) while in subpopulation NFE AF = 0.0339 (2304/67998). AF 95% confidence interval is 0.0327. There are 61 homozygotes in GnomAd4. There are 1536 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 61 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A2NM_001852.4 linkc.737C>T p.Thr246Met missense_variant, splice_region_variant Exon 14 of 32 ENST00000372748.8 NP_001843.1 Q14055

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A2ENST00000372748.8 linkc.737C>T p.Thr246Met missense_variant, splice_region_variant Exon 14 of 32 1 NM_001852.4 ENSP00000361834.3 Q14055
COL9A2ENST00000482722.5 linkn.1040C>T splice_region_variant, non_coding_transcript_exon_variant Exon 13 of 31 1
COL9A2ENST00000488463.6 linkn.788C>T splice_region_variant, non_coding_transcript_exon_variant Exon 13 of 14 5
COL9A2ENST00000417105.6 linkc.*25C>T downstream_gene_variant 5 ENSP00000388493.2 H0Y409

Frequencies

GnomAD3 genomes
AF:
0.0214
AC:
3262
AN:
152134
Hom.:
61
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00632
Gnomad AMI
AF:
0.0493
Gnomad AMR
AF:
0.0107
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.0388
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0339
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0218
AC:
5493
AN:
251406
AF XY:
0.0219
show subpopulations
Gnomad AFR exome
AF:
0.00708
Gnomad AMR exome
AF:
0.0101
Gnomad ASJ exome
AF:
0.00675
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0379
Gnomad NFE exome
AF:
0.0337
Gnomad OTH exome
AF:
0.0241
GnomAD4 exome
AF:
0.0331
AC:
48426
AN:
1461776
Hom.:
995
Cov.:
34
AF XY:
0.0323
AC XY:
23512
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.00523
AC:
175
AN:
33480
American (AMR)
AF:
0.0105
AC:
469
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00654
AC:
171
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00538
AC:
464
AN:
86256
European-Finnish (FIN)
AF:
0.0367
AC:
1962
AN:
53390
Middle Eastern (MID)
AF:
0.00763
AC:
44
AN:
5768
European-Non Finnish (NFE)
AF:
0.0389
AC:
43281
AN:
1111926
Other (OTH)
AF:
0.0308
AC:
1858
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
2656
5313
7969
10626
13282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1658
3316
4974
6632
8290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0214
AC:
3261
AN:
152252
Hom.:
61
Cov.:
32
AF XY:
0.0206
AC XY:
1536
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00631
AC:
262
AN:
41552
American (AMR)
AF:
0.0107
AC:
163
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4828
European-Finnish (FIN)
AF:
0.0388
AC:
411
AN:
10604
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0339
AC:
2304
AN:
67998
Other (OTH)
AF:
0.0152
AC:
32
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
170
340
510
680
850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0283
Hom.:
219
Bravo
AF:
0.0202
TwinsUK
AF:
0.0378
AC:
140
ALSPAC
AF:
0.0345
AC:
133
ESP6500AA
AF:
0.00931
AC:
41
ESP6500EA
AF:
0.0345
AC:
297
ExAC
AF:
0.0222
AC:
2694
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.0322
EpiControl
AF:
0.0300

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Oct 12, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Epiphyseal dysplasia, multiple, 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Connective tissue disorder Benign:1
Feb 12, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
0.18
DANN
Benign
0.60
DEOGEN2
Benign
0.040
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.0079
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.0
L
PhyloP100
-0.17
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.21
Sift
Benign
0.22
T
Sift4G
Benign
0.17
T
Polyphen
0.0020
B
Vest4
0.17
MPC
0.77
ClinPred
0.014
T
GERP RS
-9.3
Varity_R
0.026
gMVP
0.21
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00011
dbscSNV1_RF
Benign
0.044
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228565; hg19: chr1-40775937; COSMIC: COSV107474538; COSMIC: COSV107474538; API